RPRX - ROYALTY PHARMA PLC
This page shows which of the focused investors we track hold RPRX and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2026 it was held by 3 managers with an aggregate reported value of $314.96M, which is 0.03% of the combined portfolio.
As of Q1 2026, 3 tracked institutional managers held RPRX (ROYALTY PHARMA PLC) with an aggregate reported value of $314.96M — 0.03% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades RPRX — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2026
- Ticker
- RPRX
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Samantha McLemore - Patient Capital Management | 6.52% | Add +9.3% | 3,643,716 | $174.79M |
| 2 | Pat Dorsey - Dorsey Asset Management | 8.70% | Add +0.8% | 2,276,570 | $109.21M |
| 3 | Torray Funds - Torray Funds | 4.54% | Reduce -13.3% | 645,425 | $30.96M |
Loading holder history for RPRX…